Bioactivity:

FGTI-2734 can prevent membrane localization of KRAS, hence solving KRAS resistance problem and thwarting mutant KRAS patient-derived pancreatic tumors.�FGTI-2734 is a RAS C-terminal mimetic dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (

CAS nr:

1247018-19-4

Purity:

98%

Molecular Weight:

510,63

SMILES:

O=S(C1=NC=CC=C1)(N(CCN(C2=CC=C(C#N)C=C2F)CC3=CN=CN3C)CC4CCCCC4)=O

Formula:

C26H31FN6O2S

Pathway:

Others

Target:

Others